|
2025
|
Invention
|
Urokinase plasminogen activator surface receptor (upar) ligands for diagnostic or therapeutic use... |
|
2024
|
Invention
|
P-cadherin ligands. The present invention is related to a P-cadherin binding compound; a composit... |
|
|
G/S
|
Diagnostic reagents for medical use; diagnostic preparations for medical purposes; diagnostic bio... |
|
|
G/S
|
Diagnostic radiopharmaceutical preparations for use in detecting fibrosis, arthritis, atheroscler... |
|
|
G/S
|
Diagnostic reagents for medical use; diagnostic preparations
for medical purposes; diagnostic bi... |
|
|
Invention
|
Gastric inhibitory peptide receptor ligands with bio-distribution modifier. The present invention... |
|
2023
|
Invention
|
Prostate specific membrane antigen (psma) ligands and use thereof. The present disclosure is rela... |
|
2022
|
Invention
|
Carbonic anhydrase ix ligands. The present invention relates to a chemical compound; a peptide; a... |
|
|
Invention
|
Gastric inhibitory peptide receptor ligands.
The present invention is related to compound compri... |
|
|
Invention
|
Gastric inhibitory peptide receptor ligands. The present invention is related to compound compris... |
|
|
Invention
|
Fibroblast activation protein inhibitors and use thereof.
The present invention is related to a ... |
|
|
Invention
|
Fibroblast activation protein inhibitors and use thereof. The present invention is related to a c... |
|
|
Invention
|
Compounds comprising a fibroblast activation protein ligand and use thereof.
The present inventi... |
|
2021
|
Invention
|
Radiolabelled prostate specific membrane antigen (psma) inhibitors and use thereof. The present d... |
|
2020
|
Invention
|
Neurotensin receptor ligands.
The present invention is related to a compound of formula (I) wher... |
|
|
Invention
|
Compounds comprising a fibroblast activation protein ligand and use thereof. The present inventio... |
|
2017
|
G/S
|
Technological consultation and research in the field of chemical analysis; Analysis of industrial... |
|
|
G/S
|
Chemicals for use in industry and science; biological
preparations (other than for medical or ve... |
|
|
G/S
|
Chemicals for use in industry and science; Biological preparations (other than for medical or vet... |
|
|
G/S
|
Custom design and development of biological and chemical reagents and biochemical assays; scienti... |
|
|
G/S
|
Chemicals used in industry and science, namely preparations for chromatography, for purifying and... |
|
2016
|
G/S
|
Biological and chemical reagents and preparations for laboratory, scientific, or medical research... |
|
2015
|
Invention
|
Determination of binding constants by means of equilibrium shifting. There are disclosed a method... |
|
|
Invention
|
Conjugate comprising a neurotensin receptor ligand and use thereof. 7 is a bond; or a pharmacolog... |
|
|
Invention
|
Conjugate comprising a neurotensin receptor ligand and use thereof. The present invention is rela... |
|
|
Invention
|
Peptides and methods of use. The invention provides peptides, including peptides that bind and, o... |
|
2013
|
Invention
|
Neurotensin receptor ligands. 7 is selected from the group consisting of H and an Effector moiety... |
|
|
Invention
|
Neurotensin receptor ligands. The present invention is related to a compound of formula (I) where... |
|
2009
|
Invention
|
Tfpi inhibitors and methods of use. The invention provides peptides that bind Tissue Factor Pathw... |
